Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1999 1
2000 1
2003 1
2007 1
2010 1
2014 2
2015 1
2016 2
2017 1
2018 1
2019 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

13 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Outcomes of touch therapies during bone marrow transplant.
Smith MC, Reeder F, Daniel L, Baramee J, Hagman J. Smith MC, et al. Altern Ther Health Med. 2003 Jan-Feb;9(1):40-9. Altern Ther Health Med. 2003. PMID: 12564350 Clinical Trial.
It is important, therefore, to document the effects of these interventions on patient outcomes. OBJECTIVE: To investigate the effects of Therapeutic Touch and massage therapy on the outcomes of engraftment time, complications, and perceived benefits of …
It is important, therefore, to document the effects of these interventions on patient outcomes. OBJECTIVE: To investigate the effects …
Late effects in survivors of acute leukemia treated with hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study.
Baker KS, Ness KK, Weisdorf D, Francisco L, Sun CL, Forman S, Bhatia S. Baker KS, et al. Leukemia. 2010 Dec;24(12):2039-47. doi: 10.1038/leu.2010.210. Epub 2010 Sep 23. Leukemia. 2010. PMID: 20861916 Free PMC article.
The Bone Marrow Transplant Survivor Study is a retrospective cohort study in which participants who received hematopoietic cell transplantation (HCT) between 1974 and 1998 and survived for 2 years completed a 255-item questionnaire on late effects occu …
The Bone Marrow Transplant Survivor Study is a retrospective cohort study in which participants who received hematopoie …
Sterile v aseptic non-touch technique for needle-less connector care on central venous access devices in a bone marrow transplant population: A comparative study.
Flynn JM, Keogh SJ, Gavin NC. Flynn JM, et al. Eur J Oncol Nurs. 2015 Dec;19(6):694-700. doi: 10.1016/j.ejon.2015.05.003. Epub 2015 Jun 6. Eur J Oncol Nurs. 2015. PMID: 26059324
PURPOSE: The aim of this study was to determine whether a variation in practice from an aseptic non-touch technique (ANTT) to a sterile technique when changing needleless connectors on central venous access devices (CVAD) was associated with any change in catheter related …
PURPOSE: The aim of this study was to determine whether a variation in practice from an aseptic non-touch technique (ANTT) to a steri …
The meaning of cancer therapy: bone marrow transplantation as an exemplar of therapy.
Haberman M. Haberman M. Semin Oncol Nurs. 1995 Feb;11(1):23-31. doi: 10.1016/s0749-2081(95)80039-5. Semin Oncol Nurs. 1995. PMID: 7740219 Review.
Cancer touches all dimensions of life and consequently all realms of personal meaning including people's beliefs in an orderly and controllable world. ...A qualitative study of 23 adults with leukemia who were waiting to undergo a bone marrow transp
Cancer touches all dimensions of life and consequently all realms of personal meaning including people's beliefs in an orderly …
Acquired aplastic anemia in Korean children: treatment guidelines from the Bone Marrow Failure Committee of the Korean Society of Pediatric Hematology Oncology.
Kook H, Chung NG, Kang HJ, Im HJ. Kook H, et al. Int J Hematol. 2016 Apr;103(4):380-6. doi: 10.1007/s12185-016-1956-8. Epub 2016 Feb 19. Int J Hematol. 2016. PMID: 26894608 Review.
The treatment of choice for aplastic anemia (AA) in children has been HLA-matched family donor (MFD) hematopoietic stem cell transplantation (HSCT). For those lacking MFD, immunosuppressive therapy (IST) consisting of horse antithymocyte globulin (ATG) and cyclospor …
The treatment of choice for aplastic anemia (AA) in children has been HLA-matched family donor (MFD) hematopoietic stem cell transplantat
High-dose melphalan and stem cell transplantation in systemic AL amyloidosis in the era of novel anti-plasma cell therapy: a comprehensive review.
Varga C, Comenzo RL. Varga C, et al. Bone Marrow Transplant. 2019 Apr;54(4):508-518. doi: 10.1038/s41409-018-0284-4. Epub 2018 Aug 8. Bone Marrow Transplant. 2019. PMID: 30089901 Review.
The application of high-dose melphalan and autologous stem cell transplant (SCT) to systemic AL amyloidosis (AL) has evolved over the past two decades and remains an important component of therapy for patients with AL. ...In this review, we touch on the histo …
The application of high-dose melphalan and autologous stem cell transplant (SCT) to systemic AL amyloidosis (AL) has evolved over the …
Brief Report: Healing Touch Consults at a Tertiary Care Children's Hospital.
Schlefman A, Rappaport DI, Adams-Gerdts W, Stubblefield SC. Schlefman A, et al. Hosp Pediatr. 2016 Feb;6(2):114-8. doi: 10.1542/hpeds.2015-0203. Hosp Pediatr. 2016. PMID: 26822561
BACKGROUND AND OBJECTIVES: Components of complementary and alternative medicine are increasingly being implemented at academic medical centers. These approaches include therapeutic touch or healing touch (HT), an energy-based therapy using light touch
BACKGROUND AND OBJECTIVES: Components of complementary and alternative medicine are increasingly being implemented at academic medical cente …
Indications and role of allogeneic bone marrow transplantation in childhood very high risk acute lymphoblastic leukemia in first complete remission.
Uderzo C. Uderzo C. Haematologica. 2000 Nov;85(11 Suppl):9-11. Haematologica. 2000. PMID: 11268333 Review.
The objective of this review is to point out the role of allogenic bone marrow transplantation (alloBMT) in very high risk childhood ALL on the basis of results from the current clinical trials. ...The principal biases of the retrospective studies were the va …
The objective of this review is to point out the role of allogenic bone marrow transplantation (alloBMT) in very high r …
Bone marrow mesenchymal stromal cells and olfactory ensheathing cells transplantation after spinal cord injury--a morphological and functional comparison in rats.
Torres-Espín A, Redondo-Castro E, Hernández J, Navarro X. Torres-Espín A, et al. Eur J Neurosci. 2014 May;39(10):1704-17. doi: 10.1111/ejn.12542. Epub 2014 Mar 18. Eur J Neurosci. 2014. PMID: 24635194
Cell therapy for spinal cord injury (SCI) is a promising strategy for clinical application. Both bone marrow mesenchymal stromal cells (MSCs; also known as bone marrow-derived 'mesenchymal stem cells') and olfactory ensheathing cells (OECs) have …
Cell therapy for spinal cord injury (SCI) is a promising strategy for clinical application. Both bone marrow mesenchyma …
Risk factors for depression in patients undergoing hematopoietic cell transplantation.
Artherholt SB, Hong F, Berry DL, Fann JR. Artherholt SB, et al. Biol Blood Marrow Transplant. 2014 Jul;20(7):946-50. doi: 10.1016/j.bbmt.2014.03.010. Epub 2014 Mar 18. Biol Blood Marrow Transplant. 2014. PMID: 24650679 Free PMC article.
Despite the prevalence and known adverse impacts of depression after hematopoietic cell transplantation (HCT), little is known about the trajectory of depression occurring after HCT, or which pretransplantation risk factors might help predict new or worsening post-HCT depr …
Despite the prevalence and known adverse impacts of depression after hematopoietic cell transplantation (HCT), little is known about …
13 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page